Natera to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Natera, Inc. (NASDAQ: NTRA), a leader in cell-free DNA testing, is set to present at two upcoming investor conferences. The first is the Raymond James 44th Annual Institutional Investors Conference on March 7 at 2:50 p.m. ET in Orlando, FL. The second is the Cowen 43rd Annual Health Care Conference on March 8 at 11:10 a.m. ET in Boston, MA. Live webcasts will be available on the Natera investor relations website, with replays accessible shortly after each event. Natera focuses on personalized genetic testing in oncology, women's health, and organ health, supported by over 100 peer-reviewed publications.

AUSTIN, Texas--(BUSINESS WIRE)-- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that members of its management team will present at the following investor conferences:

• Raymond James 44th Annual Institutional Investors Conference on Tuesday, March 7 at 2:50 p.m. ET in Orlando, FL
• Cowen 43rd Annual Health Care Conference on Wednesday, March 8 at 11:10 a.m. ET in Boston, MA

A live webcast and audio archive of each event may be accessed through the investor relations section of the Natera website at investor.natera.com. A replay of each event will be available shortly following the conferences.

About Natera

Natera™ is a global leader in cell-free DNA testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health, and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are validated by more than 100 peer-reviewed publications that demonstrate high accuracy. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California. For more information, visit www.natera.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230224005091/en/

Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-405-4709, investor@natera.com

Media: Lesley Bogdanow, VP of Corporate Communications, Natera, Inc., pr@natera.com

Source: Natera, Inc.

FAQ

When will Natera present at the Raymond James Conference?

Natera will present at the Raymond James 44th Annual Institutional Investors Conference on March 7 at 2:50 p.m. ET.

What is the date and time of Natera's presentation at the Cowen Conference?

Natera will present at the Cowen 43rd Annual Health Care Conference on March 8 at 11:10 a.m. ET.

Where can I watch Natera's investor conference presentations?

You can watch Natera's presentations via live webcasts on their investor relations website.

What focus areas does Natera specialize in?

Natera specializes in cell-free DNA testing for oncology, women's health, and organ health.

How many peer-reviewed publications validate Natera's tests?

Natera's tests are validated by over 100 peer-reviewed publications.